AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Scope & Guideline
Connecting Discoveries to Clinical Impact in Respiratory Medicine
Introduction
Aims and Scopes
- Cellular Mechanisms in Lung Disease:
Research articles often explore the cellular mechanisms involved in various lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. This includes studies on cellular signaling pathways, immune responses, and cellular interactions. - Molecular Pathways and Therapeutics:
The journal highlights studies that investigate molecular pathways involved in lung disease progression and resolution, as well as potential therapeutic targets for intervention. - Respiratory Infections and Inflammation:
A significant focus is placed on understanding the impact of respiratory infections (such as COVID-19) on lung health, including the inflammatory responses and potential long-term effects on lung function. - Stem Cell and Regenerative Medicine:
Research on stem cell biology, especially concerning lung repair and regeneration, is a core area, with studies exploring the roles of various stem cell types in the maintenance of lung homeostasis. - Environmental Influences on Lung Health:
The journal publishes studies examining the effects of environmental factors, such as tobacco smoke, air pollution, and microbial exposure, on lung biology and disease. - Translational Research:
There is a strong emphasis on translational research that bridges the gap between laboratory findings and clinical applications, aiming to improve therapeutic strategies for lung diseases.
Trending and Emerging
- Single-Cell Analysis Techniques:
There is a notable increase in studies utilizing single-cell RNA sequencing and other single-cell technologies to dissect the cellular heterogeneity within the lung, particularly in the context of diseases like asthma and pulmonary fibrosis. - Role of the Microbiome:
Emerging research examines the role of the lung microbiome and its interactions with host immunity, indicating a trend towards understanding how microbial communities influence lung health and disease. - Immunotherapy and Precision Medicine:
The journal is witnessing a rise in articles focused on immunotherapy and precision medicine approaches for treating respiratory diseases, reflecting a broader trend towards personalized medicine. - Long COVID and Post-Acute Sequelae:
Research addressing the long-term effects of COVID-19, including post-acute sequelae, has surged, highlighting the need to understand the mechanisms and impacts of this emerging health crisis. - Metabolic Pathways in Lung Disease:
An increasing number of studies are focusing on the metabolic pathways involved in lung diseases, linking metabolic dysregulation to disease mechanisms and potential therapeutic targets.
Declining or Waning
- Basic Mechanistic Studies:
There appears to be a waning interest in purely basic mechanistic studies without clear translational implications. Researchers are increasingly seeking to connect their findings to clinical applications. - Single-Agent Therapeutic Approaches:
The focus on single-agent therapeutic approaches is declining as there is a growing recognition of the complexity of lung diseases, prompting a shift towards combination therapies and multi-target strategies. - Traditional In Vivo Models:
There is a decreasing emphasis on traditional animal models for studying lung diseases, as researchers explore more sophisticated models, including human organoids and in vitro systems that better mimic human physiology. - Chronic Inflammation Studies:
While chronic inflammation remains a key area of interest, the frequency of studies solely focused on chronic inflammation markers without integrating them into broader disease mechanisms has decreased.
Similar Journals
Thoracic Research and Practice
Pioneering Discoveries in Pulmonary and Respiratory MedicineThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
Zeitschrift fur Pneumologie
Bridging Research and Practice in Respiratory MedicineZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Chronic Respiratory Disease
Driving excellence in respiratory disease research.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
RESPIROLOGY
Fostering Excellence in Pulmonary StudiesRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
RESPIRATION
Illuminating the Path in Pulmonary and Respiratory MedicineRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Annals of the American Thoracic Society
Transforming respiratory medicine with timely and relevant contributions.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
EXPERIMENTAL LUNG RESEARCH
Innovating Approaches to Respiratory HealthEXPERIMENTAL LUNG RESEARCH, published by Taylor & Francis Inc, is a pivotal journal within the field of pulmonary and respiratory medicine, with its extensive coverage spanning from 1980 to 2024. The journal is indexed with ISSN 0190-2148 and E-ISSN 1521-0499, marking its commitment to disseminating high-quality research. With its Category Quartile rankings falling within Q3 in Clinical Biochemistry, Molecular Biology, and Pulmonary and Respiratory Medicine as of 2023, EXPERIMENTAL LUNG RESEARCH serves as a crucial platform for researchers and professionals seeking to explore innovative findings and advancements in lung physiology, pathology, and therapeutic approaches. Although currently not Open Access, it offers substantial insights through rigorous peer-reviewed articles that contribute significantly to the scientific community's understanding of respiratory health. With Scopus rankings reflecting its relevance within its categories, this journal attracts a diverse readership interested in advancing the field of lung research.
RESPIRATORY RESEARCH
Championing Open Access to Respiratory DiscoveriesRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
RESPIRATORY MEDICINE
Unraveling Complexities of Respiratory ConditionsRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
DNA AND CELL BIOLOGY
Exploring the Frontiers of Molecular DiscoveryDNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.